Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2010
11/17/2010CN101884645A Powder for treating infantile convulsions
11/17/2010CN101884640A Application of oryzanol
11/17/2010CN101884638A Application of 5alpha-androstane-3beta,5,6beta-triol in preparing neuro-protective medicaments
11/17/2010CN101884630A Taltirelin solid preparation
11/17/2010CN101884626A Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
11/17/2010CN101884624A Long-acting benserazide sustained release microsphere composition and preparation method thereof
11/17/2010CN101884623A Levodopa methyl ester slow-release microsphere composition and preparation method thereof
11/17/2010CN101884622A Benserazide sustained-release microspherical composition and preparation method thereof
11/17/2010CN101884619A Zolpidem tartrate controlled-release pellet and preparation method thereof
11/17/2010CN101884617A Method for preparing proanthocyanidins liposomes
11/17/2010CN101884614A Preparation of brain targeting chuanxiongzine oral oil package oil nano-emulsion
11/17/2010CN101391048B Medicine for treating headache
11/17/2010CN101380399B Medicine composition of protracted withdrawal syndrome after heroin-addicts detoxify
11/17/2010CN101288648B Easy-to-administrate oxiracetam granular formulation and preparation method
11/17/2010CN101259234B Medicinal composition for treating senile dementia and preparation thereof
11/17/2010CN101255407B Immortalized rat marrow stroma cell system and preparation method thereof
11/17/2010CN101244084B Sobering-up agent of pearl oyster and preparation thereof
11/17/2010CN101181057B Orally taken medicinal food for curing neurasthenia
11/17/2010CN101080231B Method for preparing galantamine hydrobromide
11/17/2010CN101077188B Medicinal diet for strengthening brain and improving eyesight students nutrition food
11/17/2010CN101073666B Method for producing kallidin proenzyme raw-material medicine
11/17/2010CN101011466B Method for extraction of gelsemium alkaloids
11/16/2010US7834237 Membrane-localisable fusion protein of an aggregating portion induced through conformational polymerisation
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834053 2-[[3-(2-benzo[b]thiophen-5-yl-ethoxy)propyl](methyl)amino]-1-ethanol; antihypoxic agent; synergistic mixture with acetylcholine esterase inhibitor (Tacrine, Donepezil, Rivastigmine); neurodegenerative diseases, ischemic cerebral lesion, cerebral apoplexy, Alzheimer's disease, cognition activator
11/16/2010US7834040 Isoxazolic derivative to relieve neuropathic pain
11/16/2010US7834022 enzyme inhibitor for treating immune-related diseases, skin disorders, myeloid proliferative disorders, cancer; allograft rejection or graft versus host disease
11/16/2010US7834020 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia
11/16/2010US7834014 Parkinson's disease; [2-(7-amino-2-furan-2-yl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)-octahydro-pyrido[1,2-a]pyrazin-7-yl]-methanol;
11/16/2010US7834008 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
11/16/2010US7834006 antidiabetics; lower blood glucose levels; compounds based on 1H,2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-e][1,4]diazepin-6-one
11/16/2010US7833999 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide
11/16/2010US7833998 cephalosporin sulfoxides or sulfones; carboxypeptidase E inhibitors; neurological disease, a behavioral disorder, or a cognitive disorder;
11/16/2010US7833993 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia
11/16/2010US7833984 modulator of PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof; treatment of pain, cancer
11/16/2010US7833973 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions
11/16/2010US7833742 Fabry disease; X-linked inherited lysosomal storage disease characterized by severe renal impairment, angiokeratomas, and/or cardiovascular abnormalities; selecting a human alpha -Gal A preparation having a desired pharmacokinetic parameter
11/16/2010US7833722 Ligands for G protein-coupled receptor protein and use thereof
11/16/2010US7833553 Sulfur-containing proanthocyanidin oligomer compositon and process for producing the same
11/16/2010CA2510655C Uses of adenosine a2a receptor antagonists
11/16/2010CA2479084C Vdac regulator
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2471220C Novel alkansulfonamides as endothelin antagonists
11/16/2010CA2455621C Use of (r/s)-(-/+) or (s)-(+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane for the treatment of extrapyramidal movement disorders
11/16/2010CA2455223C Crfr1 selective ligands
11/16/2010CA2452114C Tgf-.beta. superfamily production/secretion promoter
11/16/2010CA2436846C Thioether substituted imidazoquinolines
11/16/2010CA2430897C Liposomal composition comprising water-soluble corticosteroids for the treatment of inflammatory disorders
11/16/2010CA2427548C Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2416535C Non-sedating barbiturate compounds as neuroprotective agents
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/16/2010CA2396824C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/16/2010CA2383146C Therapeutic agent for neuropathic pain and neuropathic pain animal model
11/16/2010CA2315878C Kappa receptor opioid peptides
11/16/2010CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition
11/11/2010WO2010129791A1 Rna targeting in alpha-synucleinopathies
11/11/2010WO2010129674A2 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
11/11/2010WO2010129665A2 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
11/11/2010WO2010129276A2 PYRO-GLUTAMATE Aβ TARGETING AGENTS
11/11/2010WO2010129273A2 Butaclamol for the treatment of amyotrophic lateral sclerosis
11/11/2010WO2010129145A2 Methods and compositions for treating dry eye
11/11/2010WO2010128995A1 Phenoxymethyl heterocyclic compounds
11/11/2010WO2010128873A1 Combination of an opioid analgesic and an n-type calcium channel blocker for treating chronic pain
11/11/2010WO2010128807A2 Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases
11/11/2010WO2010128696A1 Composition for preventing and treating anxiety disorder, containing cholinergic enhancer
11/11/2010WO2010128398A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
11/11/2010WO2010128345A1 Kynurenic acid analogues, pharmaceutical compositions containing same and use of said compounds for the treatment of headache
11/11/2010WO2010128038A1 Hydroquinone derivatives
11/11/2010WO2010127978A1 Isoxazole-pyridine derivatives as gaba modulators
11/11/2010WO2010127976A1 Isoxazole-pyridine derivatives
11/11/2010WO2010127975A1 Isoxazole-pyrazole derivatives
11/11/2010WO2010127974A1 Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders
11/11/2010WO2010127855A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/11/2010WO2010127640A1 High penetration prodrug compositions of peptides and peptide-related compounds
11/11/2010WO2010127439A1 Ammo acid derivatives for the treatment of neuropathic pain
11/11/2010WO2010096371A3 Heterocyclic compounds which modulate the cb2 receptor
11/11/2010WO2010092015A8 Urea triazolo [1, 5-a] pyridine derivatives as pi3k inhibitors
11/11/2010WO2010054138A3 Modulators of atp-binding cassette transporters
11/11/2010WO2010042886A3 Pyrones for the treatment of metabolic disorders
11/11/2010WO2009135581A9 Nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/11/2010US20100287627 Transgenic Zebrafish Models for Neurodegenerative Diseases
11/11/2010US20100287626 Method of screening ptp zeta activity promoter or inhibitor
11/11/2010US20100286762 Compositions and Methods for Ameliorating Clinical Electrical Disturbances
11/11/2010US20100286284 5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h-cyclopropa[a]naphthalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde as medicaments
11/11/2010US20100286282 Exo-s-mecamylamine formulation and use in treatment
11/11/2010US20100286276 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof
11/11/2010US20100286275 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
11/11/2010US20100286273 Food supplement
11/11/2010US20100286264 Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain
11/11/2010US20100286260 Milnacipran formulations
11/11/2010US20100286248 Human fg01 gene and its applications
11/11/2010US20100286247 Methods of Protection from Oxidative Stress
11/11/2010US20100286242 siRNA-Mediated Gene Silencing of Synuclein
11/11/2010US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
11/11/2010US20100286233 Peripheral and neural inflammatory crosstalk
11/11/2010US20100286226 Combination therapy related to serotonin dual action compounds
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286219 1, 3-Dihydroimidazoles for Treating Cardiovascular Disorders
1 ... 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 ... 1833